Nashrieh Shimi va Mohandesi Shimi Iran

Nashrieh Shimi va Mohandesi Shimi Iran

Artificial Neural Networks (ANN) for Polymeric Nanoparticle Properties Prediction Based on PLGA for Drug Delivery

Document Type : Research Article

Authors
Sara Mihandoost 1
Sima Rezvantalab 2
1 Department of Electrical Engineering, Faculty of Industrial Technologies, Urmia University of Technology, Urmia, I.R. IRAN
2 Department of Chemical Engineering, Faculty of Renewable Energy, Urmia University of Technology, Urmia, I.R. IRAN
Abstract
There is a complex relationship between the properties of Poly (Lactic-Co-Glycolic Acid) (PLGA) and its Nanoparticle (NP) synthesis parameters that affect its performance as a drug delivery system. In the current study because of the complexity of the data, artificial neural networks were used to predict the impact of input variables on the performance, including NP size, Encapsulation Efficiency (E.E.%), and Drug Loading (D.L.%). In the current study, over 180 data gathered from literarture via data minig method. The effective parameters can be classified into two main groups: intrinsic polymer properties and parameters associated with the synthesis process. The individual effects of each of these parameters, their combination as third set, and finally target parameters have also been added to them as 4th set are thoroughly examined. The results revealed that considering all parameters as 4th set provides higher accuracy (R2 = 0.93) in NP size prediction. At the same time, E.E. % and D.L. % are primarily influenced by synthesis parameters (R2 = 0.96) and polymer intrinsic properties (R2 = 0.92), respectively. Sensitivity analysis for the effect of each parameter has revealed that presence of PEG in the formulation, NPs size, and synthesis method are the most effective parameters in prediction of NPs size,  E.E. % and D.L. %, respectively.
Keywords
PLGA
Drug delivery
Neural networks
Polymer

Subjects

[1] Begines B., Ortiz T., Pérez-Aranda M., Martínez G., Merinero M., Argüelles-Arias F., Alcudia A., Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects. Nanomaterials, 10(7): 1403 (2020).
[2] Khalid M., El-Sawy H.S., Polymeric Nanoparticles: Promising Platform for Drug Delivery. International journal of pharmaceutics, 528(1-2): 675-691 (2017).
[3] Shokeen M., Pressly E.D., Hagooly A., Zheleznyak A., Ramos N., Fiamengo A.L., Welch M.J., Hawker C.J., Anderson C.J., Evaluation of Multivalent, Functional Polymeric Nanoparticles for Imaging Applications. ACS nano, 5(2): 738-747 (2011).
[4] Reyes-Ortega F., Delgado Á.V., Schneider E.K., Checa Fernández B.L., Iglesias G.R., Magnetic Nanoparticles Coated with a Thermosensitive Polymer with Hyperthermia Properties. Polymers, 10(1): 10 (2017).
[5] Werner M.E., Copp J.A., Karve S., Cummings N.D., Sukumar R., Li C., Napier M.E., Chen R.C., Cox A.D., Wang A.Z., Folate-Targeted Polymeric Nanoparticle Formulation of Docetaxel is an Effective Molecularly Targeted Radiosensitizer with Efficacy Dependent on the Timing of Radiotherapy. ACS nano, 5(11): 8990-8998 (2011).
[6] Li J., Rao J., Pu K., Recent Progress on Semiconducting Polymer Nanoparticles for Molecular Imaging and Cancer Phototherapy. Biomaterials, 155: 217-235 (2018).
[7] Kamaly N., Yameen B., Wu J., Farokhzad O.C., Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. Chemical reviews, 116(4): 2602-2663 (2016).
[8] Sabbagh F., Kim B.S., Recent Advances in Polymeric Transdermal Drug Delivery Systems. Journal of controlled release, 341: 132-146 (2022).
[9] Placci M., Giannotti M.I., Muro S., Polymer-Based Drug Delivery Systems Under Investigation for Enzyme Replacement and Other Therapies of Lysosomal Storage Disorders. Advanced drug delivery reviews, 197: 114683 (2023).
[10] کرمی م.ح.، عبدوس م.، کلایی م.ر.، مرادی ا.، نانو حامل­های پایه کیتوسان برای رهایش داروی ضد سرطان کورکومین: مطالعه مروری. نشریه شیمی و مهندسی شیمی ایران، 42(4): 1 تا 17 (1402)
[11] Narmani A., Jahedi R., Bakhshian-Dehkordi E., Ganji S., Nemati M., Ghahramani-Asl R., Moloudi K., Hosseini S.M., Bagheri H., Kesharwani P., Khani A., Biomedical Applications of PLGA Nanoparticles in Nanomedicine: Advances in Drug Delivery Systems and Cancer Therapy. Expert Opinion on Drug Delivery, 20(7): 937-954 (2023).
[12] Razavi M.S., Abdollahi A., Malek-Khatabi A., Ejarestaghi N.M., Atashi A., Yousefi N., Ebrahimnejad P., Elsawy M.A., Dinarvand R., Recent Advances in PLGA-Based Nanofibers as Anticancer Drug Delivery Systems. Journal of Drug Delivery Science and Technology, 85: 104587 (2023).
[13] Han F.Y., Thurecht K.J., Whittaker A.K., Smith M.T., Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading. Frontiers in pharmacology, 7: 185 (2016).
[14] Qin C., Dong J., Xie B., Wang H., Zhang N., Zhao C., Qiao C., Liu M., Yang X., Li T.,  Synthesis, Characterization and Application of Poly (lactic-co-glycolic acid) with a Mass Ratio of Lactic to Glycolic Segments of 52/48. Chemical Research in Chinese Universities, 39(2): 290-295 (2023).
[15] Zhu B., Jin Y., Hu X., Zheng Q., Zhang S., Wang Q., Zhu J., Poly (Dimethylsiloxane) Thin Film as a Stable Interfacial Layer for High‐Performance Lithium‐Metal Battery Anodes. Advanced Materials, 29(2): 1603755 (2017).
[16] Mendoza-Muñoz N., Alcalá-Alcala S., Quintanar-Guerrero D., Preparation of Polymer Nanoparticles by the Emulsification-Solvent Evaporation Method: from Vanderhoff’s Pioneer Approach to Recent Adaptations, Polymer nanoparticles for nanomedicines, 87-121 (2016).
[17] Angelova N., Hunkeler D., Rationalizing the Design of Polymeric Biomaterials. Trends in biotechnology, 17(10): 409-421 (1999).
[18] Tao H., Wu T., Aldeghi M., Wu T.C., Aspuru-Guzik A., Kumacheva E., Nanoparticle Synthesis Assisted by Machine Learning. Nature reviews materials, 6(8): 701-716 (2021).
[19] Mekki-Berrada F., Ren Z., Huang T., Wong W.K., Zheng F., Xie J., Tian I.P.S., Jayavelu S., Mahfoud Z., Bash D., Hippalgaonkar K., Two-Step Machine Learning Enables Optimized Nanoparticle Synthesis. npj Computational Materials, 7(1): 55 (2021).
[20] Su Z., He J., Zhou P., Huang L.. Zhou J., A High-Throughput System Combining Microfluidic Hydrogel Droplets with Deep Learning for Screening the Antisolvent-Crystallization Conditions of Active Pharmaceutical Ingredients. Lab on a Chip, 20(11): 1907-1916 (2020).
[21] Jadhav A.R., Pathak P.D., Raut R.Y., Water and Wastewater Quality Prediction: Current Trends and Challenges in the Implementation of Artificial Neural Network. Environmental Monitoring and Assessment, 195(2): 321 (2023).
[22] Kumar M., Nguyen T.N., Kaur J., Singh T.G., Soni D., Singh R., Kumar P., Opportunities and Challenges in Application of Artificial Intelligence in Pharmacology. Pharmacological Reports, 75(1): 318 (2023).
[23] Kshatri S.S., Singh D., Convolutional Neural Network in Medical Image Analysis: A Review. Archives of Computational Methods in Engineering, 30(4): 2793-2810 (2023).
[24] Sorourifar F., Peng Y., Castillo I., Bui L., Venegas J., Paulson J.A., Physics-Enhanced Neural Ordinary Differential Equations: Application to Industrial Chemical Reaction Systems. Industrial & Engineering Chemistry Research, 62(38): 15563-15577 (2023).
[25] Sodeifian G., Niazi Z., Prediction of CO2 Absorption by Nanofluids Using Artificial Neural Network Modeling. International Communications in Heat and Mass Transfer, 123: 105193 (2021).
[26] Jiménez-Luna J., Grisoni F., Weskamp N., Schneider G., Artificial Intelligence in Drug Discovery: Recent Advances and Future Perspectives. Expert opinion on drug discovery, 16(9): 949-959 (2021).
[27] Zhang Y., Hu Y., Han N., Yang A., Liu X., Cai H.,  A Survey of Drug-Target Interaction and Affinity Prediction Methods Via Graph Neural Networks. Computers in Biology and Medicine, 163: 107136 (2023).
[28] Jiang M., Li Z., Zhang S., Wang S., Wang X., Yuan Q., Wei Z.,  Drug–Target Affinity Prediction Using Graph Neural Network and Contact Maps. RSC advances, 10(35): 20701-20712 (2020).
[29] Vo T.H., Nguyen N.T.K., Le N.Q.K., Improved Prediction of Drug-Drug Interactions Using Ensemble Deep Neural Networks. Medicine in Drug Discovery, 17: 100149 (2023).
[30] Sodeifian G., Sajadian S.A., Razmimanesh F., Ardestani N.S., A Comprehensive Comparison Among Four Different Approaches for Predicting the Solubility of Pharmaceutical Solid Compounds in Supercritical Carbon Dioxide. Korean Journal of Chemical Engineering, 35: 2097-2116 (2018).
[31] Sodeifian G., Sajadian S.A., Ardestani N.S., Evaluation of the Response Surface and Hybrid Artificial Neural Network-Genetic Algorithm Methodologies to Determine Extraction Yield of Ferulago Angulata Through Supercritical Fluid. Journal of the Taiwan Institute of Chemical Engineers, 60: 165-173 (2016).
[32] Baghaei B., Saeb M.R., Jafari S.H., Khonakdar H.A., Rezaee B., Goodarzi V., Mohammadi Y.,  Modeling and Closed‐Loop Control of Particle Size and Initial Burst of PLGA Biodegradable Nanoparticles for Targeted Drug Delivery. Journal of Applied Polymer Science, 134(33): 45145 (2017).
[33] Maleki H., Naghibzadeh M., Amani A., Adabi M., Khosravani M., Preparation of Paclitaxel and Etoposide Co-Loaded mPEG-PLGA Nanoparticles: An Investigation with Artificial Neural Network. Journal of Pharmaceutical Innovation, 16: 11-25 (2021).
[34] Rezvantalab S., Drude N.I., Moraveji M.K., Güvener N., Koons E.K., Shi Y., Lammers T.. Kiessling F., PLGA-based Nanoparticles in Cancer Treatment. Frontiers in pharmacology, 9: 1260 (2018).
[35] Damiati S.A., Damiati S., Microfluidic Synthesis of Indomethacin-Loaded PLGA Microparticles Optimized by Machine Learning. Frontiers in Molecular Biosciences, 8: 595 (2021).
[36] Danhier F., Ansorena E., Silva J.M., Coco R., Le Breton A., Préat V.,  PLGA-Based Nanoparticles: An Overview of Biomedical Applications. Journal of controlled release, 161(2): 505-522 (2012).
[37] Imanparast F., Faramarzi M.A., Paknejad M., Kobarfard F., Amani A., Doosti M., Preparation, Optimization, and Characterization of Simvastatin Nanoparticles by Electrospraying: An Artificial Neural Networks Study. Journal of Applied Polymer Science,. 133(28): (2016)
[38] Hastie T., Tibshirani R., Friedman J., The Elements of Statistical Learning: Data Mining, Inference, and Prediction, Springer Series in Statistics 2 (2009).
[39] Shubhra Q.T.,  Feczkó T., Kardos A.F., Tóth J., Mackova H., Horak D., Dósa G., Gyenis J., Co-Encapsulation of Human Serum Albumin and Superparamagnetic Iron Oxide in PLGA Nanoparticles: Part II. Effect of Process Variables on Protein Model Drug Encapsulation Efficiency. Journal of microencapsulation, 31(2): 156-165 (2014).
[40] Tomoda K., Terashima H., Suzuki K., Inagi T., Terada H., Makino K., Enhanced Transdermal Delivery of Indomethacin Using Combination of PLGA Nanoparticles and Iontophoresis in Vivo. Colloids and Surfaces B: Biointerfaces, 92: 50-54 (2012).
[41] Derman S., Caffeic Acid Phenethyl Ester Loaded PLGA Nanoparticles: Effect of Various Process Parameters on Reaction Yield, Encapsulation Efficiency, and Particle Size. Journal of Nanomaterials, 16(1): 1-12 (2015)
[42] Sulaiman T.N.S., Larasati D., Nugroho A.K., Choiri S., Assessment of the Effect of PLGA Co-polymers and PEG on the Formation and Characteristics of PLGA-PEG-PLGA Co-block Polymer Using Statistical Approach. Advanced Pharmaceutical Bulletin, 9(3): 382.(2019)
[43] Gan M., Zhang W., Wei S., Dang H., The Influence of mPEG-PCL and mPEG-PLGA on Encapsulation Efficiency and Drug-Loading of SN-38 NPs. Artificial cells, nanomedicine, and biotechnology, 45(2): 389-397 (2017).
[44] Song Z., Feng R., Sun M., Guo C., Gao Y., Li L., Zhai G., Curcumin-loaded PLGA-PEG-PLGA Triblock Copolymeric Micelles: Preparation, Pharmacokinetics and Distribution in Vivo. Journal of colloid and interface science, 354(1): 116-123 (2011).
[45] Afshari M., Derakhshandeh K., Hosseinzadeh L., Characterisation, Cytotoxicity and Apoptosis Studies of Methotrexate-Loaded PLGA and PLGA-PEG Nanoparticles. Journal of microencapsulation, 31(3): 239-245 (2014).
[46] Valencia P.M., Pridgen E.M., Rhee M., Langer R., Farokhzad O.C., Karnik R., Microfluidic Platform for Combinatorial Synthesis and Optimization of Targeted Nanoparticles for Cancer Therapy. ACS nano, 7(12): 10671-10680 (2013).
[47] Bertrand N., Grenier P., Mahmoudi M., Lima E.M., Appel E.A., Dormont F., Lim J-M., Karnik R., Langer R. Farokhzad O.C., Mechanistic Understanding of in Vivo Protein Corona Formation on Polymeric Nanoparticles and Impact on Pharmacokinetics. Nature communications, 8: 777 (2017)
[48] Huang W., Zhang C., Tuning the Size of Poly (Lactic‐Co‐Glycolic Acid)(PLGA) Nanoparticles Fabricated by Nanoprecipitation. Biotechnology journal, 13(1): 1700203 (2018).
[49] Halayqa M., Domańska U., PLGA Biodegradable Nanoparticles Containing Perphenazine or Chlorpromazine Hydrochloride: Effect of Formulation and Release. International journal of molecular sciences, 15(12): 23909-23923 (2014).
[50] Ranjan A.P., Mukerjee A., Helson L., Vishwanatha J.K., Scale up, Optimization and Stability Analysis of Curcumin C3 Complex-Loaded Nanoparticles for Cancer Therapy. Journal of Nanobiotechnology, 10: 1-18 (2012).
[51] Budhian A., Siegel S.J., Winey K.I., Haloperidol-Loaded PLGA Nanoparticles: Systematic Study of Particle Size and Drug Content. International journal of pharmaceutics, 336(2): 367-375 (2007).
[52] Ramirez J.C., Flores-Villaseñor S.E., Vargas-Reyes E., Herrera-Ordonez J., Torres-Rincón S., Peralta-Rodríguez R.D., Preparation of PDLLA and PLGA Nanoparticles Stabilized with PVA and a PVA-SDS Mixture: Studies on Particle Size, Degradation and Drug Release. Journal of Drug Delivery Science and Technology, 60: 101907 (2020).
[53] Qi F., Wu J., Fan Q., He F., Tian G., Yang T., Ma G., Su Z.,  Preparation of Uniform-Sized Exenatide-Loaded PLGA Microspheres as Long-Effective Release System with High Encapsulation Efficiency and Bio-Stability. Colloids and surfaces B: biointerfaces, 112: 492-498 (2013).
[54] Behnke M., Vollrath A., Klepsch L., Beringer-Siemers B., Stumpf S., Czaplewska A.J., Hoeppener S., Werz O., Schubert S.U., Optimized Encapsulation of the FLAP/PGES-1 Inhibitor BRP-187 in PVA-Stabilized Plga Nanoparticles Using Microfluidics. Polymers, 12(11): 2751 (2020).
[55] Park H., Ha D.H., Ha E.S., Kim J.S., Kim M.S., Hwang S.J., Effect of Stabilizers on Encapsulation Efficiency and Release Behavior of Exenatide-Loaded PLGA Microsphere Prepared by the W/O/W Solvent Evaporation Method. Pharmaceutics, 11(12): 627 (2019).
[56] Bao Y., Maeki M., Ishida A., Tani H., Tokeshi M.,  Effect of Organic Solvents on a Production of PLGA-Based Drug-Loaded Nanoparticles Using a Microfluidic Device. ACS omega, 7(37): 33079-33086 (2022).
[57] Yu W., Liu R., Zhou Y., Gao H., Size-Tunable Strategies for a Tumor Targeted Drug Delivery System. ACS central science, 6(2): 100-116 (2020).
[58] Labouta H.I., Asgarian N., Rinker K., Cramb D.T., Meta-Analysis of Nanoparticle Cytotoxicity Via Data-Mining the Literature. ACS nano, 13(2): 1583-1594 (2019).
[59] Jones D.E., Ghandehari H., Facelli J.C., A Review of the Applications of Data Mining and Machine Learning for the Prediction of Biomedical Properties of Nanoparticles. Computer methods and programs in biomedicine, 132: 93-103 (2016).